Administration of mesenchymal stem cells during ECMO results in a rapid decline in oxygenator performance

Jonathan Edward Millar1, Viktor von Bahr1,2, Maximillian V Malfertheiner1,3

  • 1Critical Care Research Group, University of Queensland, Brisbane, Queensland, Australia.

Thorax
|April 7, 2018
PubMed

Insights

Mesenchymal stem cells (MSCs) administered during extracorporeal membrane oxygenation (ECMO) may impair oxygenator function. This study shows MSCs reduce flow and increase pressure in ECMO circuits, highlighting potential risks for severe Acute Respiratory Distress Syndrome (ARDS) patients.

Area of Science:

  • Regenerative Medicine
  • Critical Care Medicine
  • Biomedical Engineering

Background:

  • Mesenchymal stem cells (MSCs) show promise for treating Acute Respiratory Distress Syndrome (ARDS).
  • Extracorporeal membrane oxygenation (ECMO) is increasingly used for severe ARDS.
  • Current MSC trials exclude patients on ECMO.

Purpose of the Study:

  • To investigate the impact of intravascular Mesenchymal stem cell (MSC) administration on membrane oxygenator function during extracorporeal membrane oxygenation (ECMO).
  • To assess potential adverse effects of combining MSC therapy with ECMO support in a simulated setting.

Main Methods:

  • An ex-vivo model simulating ECMO circuits was utilized.
  • Clinical grade MSCs were added to the ECMO circuit, and their effect on flow and pressure was measured.
  • Immunohistochemistry was performed to analyze MSC adhesion to the oxygenator fibers.

Main Results:

  • Addition of MSCs significantly reduced circuit flow (0.6 ±0.35 L/min vs 4.12 ± 0.03 L/min at 240 min).
  • MSCs caused a marked increase in the trans-oxygenator pressure gradient (101±9 mmHg vs 21±4 mmHg at 240 min).
  • Immunohistochemistry confirmed extensive MSC adherence to membrane oxygenator fibers.

Conclusions:

  • Intravascular administration of MSCs during ECMO may adversely affect membrane oxygenator function.
  • Potential risks include reduced circuit flow and increased pressure, necessitating further research.
  • This finding is critical for advancing cell therapy translation in ECMO-supported ARDS patients.
Keywords:
Ards

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.6K
Magnetic Declination01:19

Magnetic Declination

Magnetic declination is the angle between true north, which aligns with the Earth's rotational axis, and magnetic north, which follows the direction of the Earth's magnetic field. This discrepancy exists because the magnetic poles do not coincide with the geographic poles. The value of magnetic declination depends on the observer's location on Earth and is subject to changes over time due to the dynamic nature of the Earth's magnetic field.The declination is called eastern when magnetic north...
482
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Conservation of Declining Populations02:07

Conservation of Declining Populations

Conservation of declining population focuses on ways of detecting, diagnosing, and halting a population decline. The approach uses methods to prevent populations from going extinct.
13.4K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.6K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K